These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 38501104)
1. PANoptosis-related genes function as efficient prognostic biomarkers in colon adenocarcinoma. Liu Y; Wang Y; Feng H; Ma L; Liu Y Front Endocrinol (Lausanne); 2024; 15():1344058. PubMed ID: 38501104 [TBL] [Abstract][Full Text] [Related]
2. Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms. Liang W; Yang X; Li X; Wang P; Zhu Z; Liu S; Xu D; Zhi X; Xue J Aging (Albany NY); 2024 May; 16(9):7596-7621. PubMed ID: 38742936 [TBL] [Abstract][Full Text] [Related]
3. Identification prognosis-associated immune genes in colon adenocarcinoma. Miao Y; Wang J; Ma X; Yang Y; Mi D Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821 [TBL] [Abstract][Full Text] [Related]
4. Metabolism-Related Prognostic Biomarkers, Purine Metabolism and Anti-Tumor Immunity in Colon Adenocarcinoma. Liu H; Zhang Y; Zhang Q; Zhang T; Lu T Front Biosci (Landmark Ed); 2023 Dec; 28(12):328. PubMed ID: 38179743 [TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a prognostic risk-scoring model based on sphingolipid metabolism-associated cluster in colon adenocarcinoma. Yuan Q; Zhang W; Shang W Front Endocrinol (Lausanne); 2022; 13():1045167. PubMed ID: 36518255 [TBL] [Abstract][Full Text] [Related]
6. Development of a 5-mRNAsi-related gene signature to predict the prognosis of colon adenocarcinoma. Huang H; Lu L; Li Y; Chen X; Li M; Yang M; Huang X PeerJ; 2023; 11():e16477. PubMed ID: 38025763 [TBL] [Abstract][Full Text] [Related]
7. A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma. Gao H; Xing F BMC Med Inform Decis Mak; 2022 Oct; 22(1):277. PubMed ID: 36273131 [TBL] [Abstract][Full Text] [Related]
8. Identification of a novel glycolysis-related gene signature for predicting the survival of patients with colon adenocarcinoma. Yi K; Wu J; Tang X; Zhang Q; Wang B; Wang F Scand J Gastroenterol; 2022 Feb; 57(2):214-221. PubMed ID: 34644216 [TBL] [Abstract][Full Text] [Related]
9. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma. Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867 [No Abstract] [Full Text] [Related]
10. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma. He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071 [TBL] [Abstract][Full Text] [Related]
11. Glucose metabolism-based signature predicts prognosis and immunotherapy strategies for colon adenocarcinoma. Bai Z; Yan C; Nie Y; Zeng Q; Xu L; Wang S; Chang D J Gene Med; 2024 Jan; 26(1):e3620. PubMed ID: 37973153 [TBL] [Abstract][Full Text] [Related]
12. Identification and validation of 12 immune-related genes as a prognostic signature for colon adenocarcinoma. Tang D; Huang W; Yang Z; Wu X; Sang X; Wang K; Cao G J Biochem Mol Toxicol; 2021 Sep; 35(9):e22852. PubMed ID: 34396630 [TBL] [Abstract][Full Text] [Related]
13. Predictive Models for Colon Adenocarcinoma Diagnosis, Prognosis, and Immune Microenvironment Based on 2 Hypoxia-Related Genes: KDM3A and ENO3. Kong C; Zheng L; Fang S; Chen M; Lin G; Qiu R; Zhao Z; Chen W; Song J; Yang Y; Ji J Technol Cancer Res Treat; 2023; 22():15330338231195494. PubMed ID: 37650153 [No Abstract] [Full Text] [Related]
14. Analysis of PANoptosis-Related LncRNA-miRNA-mRNA Network Reveals LncRNA SNHG7 Involved in Chemo-Resistance in Colon Adenocarcinoma. Huang J; Jiang S; Liang L; He H; Liu Y; Cong L; Jiang Y Front Oncol; 2022; 12():888105. PubMed ID: 35646635 [TBL] [Abstract][Full Text] [Related]
15. A bioinformatics approach to identify a disulfidptosis-related gene signature for prognostic implication in colon adenocarcinoma. Hu G; Yao H; Wei Z; Li L; Yu Z; Li J; Luo X; Guo Z Sci Rep; 2023 Jul; 13(1):12403. PubMed ID: 37524774 [TBL] [Abstract][Full Text] [Related]
16. A novel enterocyte-related 4-gene signature for predicting prognosis in colon adenocarcinoma. Cheng X; Wei Y; Fu Y; Li J; Han L Front Immunol; 2022; 13():1052182. PubMed ID: 36532007 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma. Nan H; Guo P; Fan J; Zeng W; Hu C; Zheng C; Pan B; Cao Y; Ge Y; Xue X; Li W; Lin K Front Immunol; 2023; 14():1093974. PubMed ID: 36949947 [TBL] [Abstract][Full Text] [Related]
18. The anoikis-related gene signature predicts survival accurately in colon adenocarcinoma. Hu G; Li J; Zeng Y; Liu L; Yu Z; Qi X; Liu K; Yao H Sci Rep; 2023 Aug; 13(1):13919. PubMed ID: 37626132 [TBL] [Abstract][Full Text] [Related]
19. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy. Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y Front Immunol; 2021; 12():665002. PubMed ID: 34367132 [TBL] [Abstract][Full Text] [Related]
20. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures. Jin L; Li C; Liu T; Wang L Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]